RT Journal Article
SR Electronic
T1 LGBTQ+ Affirming Care May Increase Awareness and Understanding of Undetectable=Untransmittable among Midlife and Older Gay and Bisexual Men in the US South
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.06.20.22276658
DO 10.1101/2022.06.20.22276658
A1 Tara McKay
A1 Ellesse-Roselee Akré
A1 Jeff Henne
A1 Adam Conway
A1 Isabel Gothelf
A1 Nitya Kari
YR 2022
UL http://medrxiv.org/content/early/2022/06/23/2022.06.20.22276658.abstract
AB One of the most significant innovations in HIV prevention is the use of HIV treatment to prevent HIV transmission. This information has been disseminated as the “Undetectable = Untransmittable” (U=U) message. Despite evidence of effectiveness, U=U awareness, belief, and understanding remains limited in some communities. In this study we examine whether having an LGBTQ affirming healthcare provider increases U=U awareness, belief, and understanding among midlife and older gay and bisexual men in the US South, an understudied and underserved population and region where new HIV infections are increasing. We use data from the Vanderbilt University Social Networks Aging and Policy Study (VUSNAPS) on sexual minority men aged 50 to 76 from four Southern US states collected in 2020-2021. We find that only one in four men report prior awareness of U=U, but awareness is higher among HIV negative and HIV positive men who have an LGBTQ affirming provider. Having an affirming provider significantly increases U=U belief and understanding, improves risk perception accuracy, and increases the likelihood of having ever tested for HIV among HIV negative men. Improving access to LGBTQ affirming healthcare may improve U=U awareness, belief, and understanding, which could help to curb HIV transmission in the US South.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the National Institute on Aging (R01AG063771).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Vanderbilt University Human Research Protections Program gave ethical approval for this work, IRB #200117.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors or via www.vusnaps.com. https://www.vusnaps.com